Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN)

NCT04034056 · clinicaltrials.gov ↗

COMPLETED

Status

299

Enrollment

INDUSTRY

Sponsor class

Conditions

Follicular Lymphoma

Interventions

DRUG: Obinutuzumab

Sponsor

Hoffmann-La Roche